Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER3 | P43115 | 12/20 | 0.47 |
| ▸ | PTGER2 | P43116 | 12/20 | 0.47 |
| ▸ | PTGER4 | P35408 | 11/20 | 0.47 |
| ▸ | PTGER1 | P34995 | 8/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.40 |
| ▸ | PTGDR | Q13258 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | PTGFR | P43088 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | PTGIR | P43119 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15609193 | 0.81 | PTGER3 (0.51) | PTGER3PTGER2PTGER4PTGER1CA1 | |
| SCHEMBL15609192 | 0.81 | PTGER3 (0.51) | PTGER3PTGER2PTGER4PTGER1CA1 | |
| SCHEMBL690917 | 0.74 | CA1 (0.53) | PTGER3PTGER2PTGER4PTGER1CA1 | |
| SCHEMBL30560916 | 0.74 | CA1 (0.53) | PTGER3PTGER2PTGER4PTGER1CA1 | |
| SCHEMBL691503 | 0.74 | CA1 (0.53) | PTGER3PTGER2PTGER4PTGER1CA1 | |
| SCHEMBL29386378 | 0.73 | CA1 (0.62) | PTGER3PTGER2PTGER4PTGER1CA1 | |
| SCHEMBL2425317 | 0.73 | CA1 (0.62) | PTGER3PTGER2PTGER4PTGER1CA1 | |
| SCHEMBL78556 | 0.73 | CA1 (0.62) | PTGER3PTGER2PTGER4PTGER1CA1 | |
| SCHEMBL78555 | 0.73 | CA1 (0.62) | PTGER3PTGER2PTGER4PTGER1CA1 | |
| SCHEMBL18555493 | 0.73 | PTGER3 (0.52) | PTGER3PTGER2PTGER4PTGER1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220153786-A1 | PEPTIDES FOR PREVENTING BIOFILM FORMATION | UNIVERSITE DE RENNES 1 (FR) | 2022-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153786-A1 | PEPTIDES FOR PREVENTING BIOFILM FORMATION | NGLY1, VIP, IDUA | PTGER3 4681/4885PTGER2 4842/4885PTGER4 4273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.